On 5/11/2017, Shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) closed at $5.72 in last trading day. After noting the initial trading entry at $5.94, it reached to a day’s high of $5.97 and moved to a day’s low of $5.68. The recent daily volume was 2.53 million as contrast to it’s an average volume of 1.79 million.
The last close of the BioCryst Pharmaceuticals, Inc. stock reflects that it traded -19.53% from its 50-day moving average of $7.11. The stock traded below -10.39% to its 200-day MA of $6.38. Furthermore, it moved lower -38.16% from its 52-week high of $9.25 and +120.00% up from $2.60, which is 52-week low of the stock.
BioCryst Pharmaceuticals, Inc.’s (BCRX) moved with shift of -1.21% in the past week. Over the last three months, the shares of the company have changed -4.67% and performed 22.48% over the last six months. The stock currently has Monthly Volatility of 5.61% and Weekly Volatility of 6.78%.
PTC Therapeutics, Inc. (NASDAQ:PTCT) finalized the last transaction at value of $12.96, with a daily change of +2.94% or +0.37 points. The company maintained volume of 914.33 thousand shares. In past trading day, the stock hit the maximum price of $13.14 and touched to minimum value of $12.45. It has a market cap of $ 444.74M.
As of last trade close, the stock is trading downside -21.45% from its one year high of $16.50 and moved +221.59% upward from $4.03, which is one year low of the stock.
The stock traded above +21.72% from its 50-day moving average of $10.65. Furthermore, the stock moved up +15.12% to its 200-day MA of $ 11.26.
During the last month, PTC Therapeutics, Inc.’s (PTCT) has changed 24.38% and performed 147.80% over the last 6 months. The mean rating score for this stock is at 2.50. This rating scale contains from 1 to 5 with 5 representing a Strong Sell, 1 signifying a Strong Buy and 3 demonstrating a Hold. The Volatility was noted at 5.68% in recent month and observed Weekly Volatility of 8.57%.